A paper-based immunoassay to determine HPV vaccination status at the point-of-care

Simple item page
dc.citation.firstpage5656en_US
dc.citation.issueNumber46en_US
dc.citation.journalTitleVaccineen_US
dc.citation.lastpage5663en_US
dc.citation.volumeNumber34en_US
dc.contributor.authorGrant, Benjamin D.en_US
dc.contributor.authorSmith, Chelsey A.en_US
dc.contributor.authorCastle, Philip E.en_US
dc.contributor.authorScheurer, Michael E.en_US
dc.contributor.authorRichards-Kortum, Rebeccaen_US
dc.contributor.orgBioengineeringen_US
dc.date.accessioned2016-11-22T15:16:06Zen_US
dc.date.available2016-11-22T15:16:06Zen_US
dc.date.issued2016en_US
dc.description.abstractObjective: To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. Methods: The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. Results: For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. Conclusions: We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.en_US
dc.identifier.citationGrant, Benjamin D., Smith, Chelsey A., Castle, Philip E., et al.. "A paper-based immunoassay to determine HPV vaccination status at the point-of-care." <i>Vaccine,</i> 34, no. 46 (2016) Elsevier: 5656-5663. http://dx.doi.org/10.1016/j.vaccine.2016.09.021.en_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.vaccine.2016.09.021en_US
dc.identifier.urihttps://hdl.handle.net/1911/92711en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsThis is an open access article under the CC BY-NC-ND license.en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subject.keywordHPVen_US
dc.subject.keywordSerologic testsen_US
dc.subject.keywordpoint-of-care testingen_US
dc.titleA paper-based immunoassay to determine HPV vaccination status at the point-of-careen_US
dc.typeJournal articleen_US
dc.type.dcmiTexten_US
dc.type.publicationpublisher versionen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s2.0-S0264410X16308349-main.pdf
Size:
1.25 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Faculty Publications